The cost of a popular Vertex Pharmaceuticals therapy could be contributing to cystic fibrosis (CF) treatment disparities around the world, researchers argued in a recent paper. Just 12% of some ...
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) expanded the eligibility for ...
- For the first time, approximately 6,000 patients with one minimal function mutation and one F508del mutation have a medicine to treat the underlying cause of their disease– -12,000 people with one ...
TRIKAFTA is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients ages 6 years and older who have at least one copy of the F508del mutation in the cystic fibrosis ...
- Both studies met primary and all key secondary endpoints demonstrating significant improvements in lung function and other measures of the disease - - Results of both studies to be presented today ...
DENVER (CBS4)- The experts call it a game changer. The FDA has approved a new breakthrough treatment for cystic fibrosis. Trikafta is a combination of three drugs and the first therapy able to treat ...
On 18 May at the 2025 American Thoracic Society (ATS) International Conference, a poster presentation by Sivagurunathan Sutharsan and colleagues from University Medicine Essen, Ruhrlandklinik, ...
Yesterday, the FDA approved the use of Trikafta, a triple combination therapy, for treatment of the most common cystic fibrosis (CF) mutation. This is the first medication to be approved for use among ...
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center ...
Cystic fibrosis miracle drug Trikafta, helps 90% of people, the other 10% are still waiting for their aid. The small box full of promises arrived at Jessica Anderson’s home on her 31st birthday. A ...
The FDA’s recent approval of a three-drug combination therapy for cystic fibrosis patients is being celebrated among both patients and doctors as “life-changing” news. Trikafta, produced by Vertex ...
(RTTNews) - Vertex Pharmaceuticals (VRTX) said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results